Pliant Therapeutics (PLRX) PT Lowered to $53 at RBC Capital
Tweet
Share
E-mailGet Alerts PLRX Hot Sheet
Price: $1.08 -5.26%
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Pliant Therapeutics (NASDAQ: PLRX) to $53.00 (from $54.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,030 at Citi
- Paychex (PAYX) PT Lowered to $105 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
